尿液检查市场规模、份额、成长分析、按测试、按应用、按最终用户、按地区 - 行业预测，2025 年至 2032 年

预计2023年全球尿液检查市场规模将达到24亿美元，将从2024年的25.1亿美元扩大到2032年的35.4亿美元，预测期内（2025-2032年）的复合年增长率为4.4%。

受医疗设备（尤其是尿液分析仪和相关产品）进步的推动，尿液检查市场预计将快速成长。医疗保健基础设施的改善和日益增长的未满足的健康需求，尤其是糖尿病等慢性病的盛行率不断上升，正在推动对尿液检查解决方案的需求。政府发起的筛检项目，例如美国国立卫生研究院（NIH）在温州进行的大规模尿液筛检，有望提高疾病的早期发现率，并进一步刺激市场扩张。此外，男性和女性普遍存在的尿道感染发病率不断上升，也增加了尿液检查在诊断糖尿病和各种肾臟疾病方面发挥关键作用。整体而言，尿液检查市场在新兴市场将迎来显着成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

尿液检查市场规模：依检测方式

• 市场概况
• 妊娠和不孕症检测
• 尿液生化
• 尿沉渣检查

尿液检查市场规模（按应用）

• 市场概况
• 疾病筛检
• 怀孕和生育

尿液检查市场规模（依最终用户划分）

• 市场概况
• 医院和诊所
• 诊断实验室
• 居家照护环境
• 研究办公室/实验室

尿液检查市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• Cardinal Health（US）
• General Electric Company（US）
• Metropolis India（India）
• 77 Elektronika Kft（Hungary）
• Roche Diagnostics（Switzerland）
• Thermo Fisher Scientific（US）
• Sysmex Corporation（Japan）
• Abbott（US）
• Trinity Biotech（Ireland）
• ARKRAY Inc.（Japan）
• Dr Lal PathLabs（India）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Siemens（Germany）
• Sysmex Corporation（Japan）
• BioMaxima SA（Poland）

结论和建议

Global Urinalysis Test Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.51 billion in 2024 to USD 3.54 billion by 2032, growing at a CAGR of 4.4% during the forecast period (2025-2032).

The urinalysis test market is poised for rapid growth, driven by advancements in medical equipment, particularly in urine analyzers and related products. Improved healthcare infrastructure and rising unmet health needs, especially the increasing prevalence of chronic diseases like diabetes, are propelling demand for urine testing solutions. Screening programs initiated by governments, such as the significant urine screenings conducted by the National Institute of Health (NIH) in Wenzhou, are enhancing early disease detection and are expected to further stimulate market expansion. Additionally, the rising incidence of urinary tract infections, prevalent in both genders, is fueling the necessity for urinalysis testing, which plays a critical role in diagnosing diabetes and various renal issues. Overall, the market for urine tests is set for significant growth in emerging markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Urinalysis Test market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Urinalysis Test Market Segmental Analysis

Global Urinalysis Test Market is segmented by Application, End User, Test and region. Based on Test, the market is segmented into Pregnancy & Fertility Tests, Biochemical Urinalysis and Sediment Urinalysis. Based on Application, the market is segmented into Disease Screening and Pregnancy and Fertility. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Home Care Setting and Research Laboratories & Institute. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Urinalysis Test Market

The global urinalysis test market is primarily driven by the increasing prevalence of diabetes and urinary tract infections (UTIs), particularly in developing countries. The surge in UTI cases poses significant health risks, as untreated infections can lead to complications during childbirth and may spread to the kidneys, highlighting the critical need for timely diagnosis and treatment. As awareness of these conditions grows, the demand for urinalysis tests is expected to rise, further propelling market growth. Additionally, improved access to healthcare services and advancements in diagnostic technologies are enhancing the overall landscape of the urinalysis test market.

Restraints in the Global Urinalysis Test Market

One of the key restraints in the global urinalysis test market is the limited accessibility to advanced urine analyzers, particularly in developing countries where cost is a major concern. In these regions, healthcare providers often opt for more affordable devices that offer similar functionalities, leading to increased demand for budget-friendly alternatives. Furthermore, the lack of robust regulatory frameworks can result in an influx of substandard and refurbished products in the market, undermining the quality of diagnostic services and potentially risking patient safety. This scenario creates significant challenges for manufacturers aiming to introduce high-quality, innovative solutions in these emerging markets.

Market Trends of the Global Urinalysis Test Market

The Global Urinalysis Test market is experiencing a notable trend driven by advancements in diagnostic technology, particularly through automated urine analyzers and smartphone-integrated testing devices. These innovations enhance the precision and accessibility of urinalysis, catering to both healthcare professionals and patients. As chronic illnesses such as diabetes and kidney disease rise, the demand for efficient urinalysis tests is surging, reinforcing their integral role in early health problem detection and management. This expanding requirement for streamlined testing methods emphasizes urinalysis as a cornerstone of modern healthcare, propelling market growth and innovation in diagnostic approaches for better patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Urinalysis Test Market Size by Test & CAGR (2025-2032)

• Market Overview
• Pregnancy & Fertility Tests
• Biochemical Urinalysis
• Sediment Urinalysis

Global Urinalysis Test Market Size by Application & CAGR (2025-2032)

• Market Overview
• Disease Screening
• Pregnancy and Fertility

Global Urinalysis Test Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care Setting
• Research Laboratories & Institute

Global Urinalysis Test Market Size & CAGR (2025-2032)

• North America (Application, End User, Test)
  • US
  • Canada
• Europe (Application, End User, Test)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, End User, Test)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, End User, Test)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, End User, Test)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Cardinal Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metropolis India (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 77 Elektronika Kft (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr Lal PathLabs (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMaxima SA (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations